Abu Dhabi's M42, a recently established investment company supported by the state, is actively seeking various potential deals to establish a leading global player in AI-driven healthcare.

The company, formed through the merger of healthcare assets from two well-known Abu Dhabi investment firms, aims to expand its operations internationally.

CEO Hasan Jasem Al Nowais has expressed that M42 is focusing on acquisitions and growth opportunities in key markets such as Europe, Latin America, and Asia. This strategic move reflects Abu Dhabi's dedication to improving its healthcare sector through innovative technology and global partnerships.